A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design

Distinct CD4(+) T cell epitopes have been associated with spontaneous control of HIV-1 replication, but analysis of antigen-dependent factors that influence epitope selection is lacking. To examine these factors, we used a cell-free antigen processing system that incorporates soluble HLA-DR (DR1), HLA-DM (DM), cathepsins, and full-length protein antigens for epitope identification by LC-MS/MS. HIV-1 Gag, Pol, Env, Vif, Tat, Rev, and Nef were examined using this system. We identified 35 novel epitopes, including glycopeptides. Epitopes from smaller HIV-1 proteins mapped to regions of low protein stability and higher solvent accessibility. HIV-1 antigens associated with limited CD4(+) T cell responses were processed efficiently, while some protective epitopes were inefficiently processed. 55% of epitopes obtained from cell-free processing induced memory CD4(+) T cell responses in HIV-1(+) donors, including eight of 19 novel epitopes tested. Thus, an in vitro processing system utilizing the components of Class II processing reveals factors influencing epitope selection of HIV-1 and represents an approach to understanding epitope selection from non-HIV-1 antigens.

Automated summary

Distinct CD4(+) T cell epitopes associated with spontaneous control of HIV-1 replication were analyzed using a cell-free antigen processing system. Factors influencing epitope selection were identified, including protein stability and solvent accessibility. Efficient processing of some HIV-1 antigens was associated with limited CD4(+) T cell responses, while inefficient processing was observed for certain protective epitopes. This in vitro processing system provides insights into epitope selection for HIV-1 and non-HIV-1 antigens.